Challenge for a better combination with basic evidence-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Challenge for a better combination with basic evidence

Published:2008-06 Issue:3 Volume:13 Page:212-219
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Yoshida Kazuhiro,Yamaguchi Kazuya,Osada Shinji,Kawaguchi Yoshihiro,Takahashi Takao,Sakashita Fumio,Tanaka Yoshihiro

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-008-0793-z.pdf

Reference55 articles.

1. Parkin DM, Bray F, Ferlay J, et al. (2005) Global cancer statistics in the year 2002. CA Cancer J Clin 55:74–108

2. Preusser P, Wilke H, Achterrath W, et al. (1989) Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer. J Clin Oncol 7:1310–1317

3. Cocconi G, Bella M, Zironi S, et al. (1994) Fluorouracil, doxorubicin, and mitomycin combination versus PELF chemotherapy in advanced gastric cancer: a prospective randomized trial of the Italian oncology group for clinical research. J Clin Oncol 12:2687–2693

4. Macdonald JS, Schein PS, Wooley PV, et al. (1980) 5-Fluorouracil, doxorubicin, and mitomycin (FAM) combination chemotherapy for advanced gastric cancer. Ann Intern Med 93:533–536

5. Klein HO, Wickramanayake PD, Dieterle F, et al. (1983) High dose MTX/5-Fu and adriamycin for gastric cancer. Semin Oncol 10:29–31

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibitory effects and mechanism of 5-fluorouracil combined with celecoxib on human gastric cancer xenografts in nude mice;Experimental and Therapeutic Medicine;2014-11-18

2. Relationship Between the DPD and TS mRNA Expression and the Response to S-1-Based Chemotherapy and Prognosis in Patients with Advanced Gastric Cancer;Cell Biochemistry and Biophysics;2014-11-12

3. Synergic effect between 5-fluorouracil and celecoxib on hypoxic gastric cancer cells;Molecular Medicine Reports;2014-10-27

4. Effect of celecoxib plus standard chemotherapy on serum levels of vascular endothelial growth factor and cyclooxygenase-2 in patients with gastric cancer;Biomedical Reports;2013-12-06

5. The prognostic significance of chemotherapy for stage IV gastric cancer patients: A single-institution experience;Surgery Today;2011-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3